Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12  •  04:00PM ET
11.28
Dollar change
+0.36
Percentage change
3.30
%
Index- P/E228.34 EPS (ttm)0.05 Insider Own27.49% Shs Outstand160.61M Perf Week7.22%
Market Cap1.81B Forward P/E20.67 EPS next Y0.55 Insider Trans-0.12% Shs Float116.47M Perf Month0.98%
Enterprise Value1.96B PEG24.01 EPS next Q0.11 Inst Own78.22% Short Float11.54% Perf Quarter0.89%
Income7.98M P/S4.47 EPS this Y-3.86% Inst Trans5.13% Short Ratio8.14 Perf Half Y8.15%
Sales405.75M P/B1.69 EPS next Y26.17% ROA0.52% Short Interest13.44M Perf YTD5.92%
Book/sh6.67 P/C11.17 EPS next 5Y9.51% ROE0.76% 52W High15.69 -28.11% Perf Year2.45%
Cash/sh1.01 P/FCF18.04 EPS past 3/5Y5.33% -5.78% ROIC0.58% 52W Low8.64 30.63% Perf 3Y-27.97%
Dividend Est.- EV/EBITDA19.26 Sales past 3/5Y10.42% 13.06% Gross Margin47.46% Volatility5.28% 3.85% Perf 5Y-
Dividend TTM- EV/Sales4.82 EPS Y/Y TTM110.05% Oper. Margin7.20% ATR (14)0.48 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.16 Sales Y/Y TTM11.61% Profit Margin1.97% RSI (14)56.34 Recom2.08
Dividend Gr. 3/5Y- - Current Ratio2.16 EPS Q/Q84.42% SMA204.02% Beta1.43 Target Price14.11
Payout- Debt/Eq0.29 Sales Q/Q12.06% SMA505.02% Rel Volume1.25 Prev Close10.92
Employees1546 LT Debt/Eq0.28 EarningsAug 06 AMC SMA200-2.30% Avg Volume1.65M Price11.28
IPODec 11, 2020 Option/ShortYes / Yes EPS/Sales Surpr.-29.65% 0.50% Trades Volume2,057,903 Change3.30%
Date Action Analyst Rating Change Price Target Change
Jul-03-25Resumed Morgan Stanley Equal-Weight $16
May-08-25Upgrade Barclays Equal Weight → Overweight $14
Feb-27-25Initiated TD Cowen Buy $16
Sep-27-24Upgrade UBS Neutral → Buy $16
Apr-10-24Upgrade KeyBanc Capital Markets Sector Weight → Overweight $23
Apr-04-24Initiated JMP Securities Mkt Perform
Feb-26-24Initiated Leerink Partners Market Perform $19
Dec-07-23Initiated UBS Neutral $17
Dec-05-23Initiated KeyBanc Capital Markets Sector Weight
Aug-22-23Downgrade Jefferies Buy → Hold $24.50 → $17
Sep-04-25 08:00AM
Sep-02-25 04:15PM
Aug-07-25 03:28PM
Aug-06-25 06:00PM
04:15PM
02:00AM Loading…
Aug-04-25 02:00AM
Jul-31-25 04:15PM
10:00AM
Jul-30-25 10:00AM
Jul-29-25 08:25AM
Jul-18-25 08:38AM
Jul-15-25 01:56PM
Jul-11-25 12:10PM
Jul-10-25 12:39AM
Jul-09-25 04:15PM
12:05PM Loading…
Jul-08-25 12:05PM
08:00AM
Jun-28-25 09:10AM
Jun-20-25 08:25AM
May-23-25 09:17AM
May-06-25 08:31AM
03:09AM
May-05-25 07:22PM
05:45PM
04:15PM
Apr-29-25 04:15PM
10:01AM
Apr-28-25 10:00AM
Apr-21-25 08:00AM
Apr-16-25 12:10PM
12:40AM Loading…
Apr-15-25 12:40AM
Apr-14-25 08:15AM
08:00AM
Apr-12-25 06:45PM
02:10AM
Apr-11-25 01:15PM
10:04AM
Apr-02-25 12:49PM
Apr-01-25 08:00AM
Mar-06-25 07:58PM
Mar-05-25 04:15PM
Feb-27-25 07:59AM
02:28AM
Feb-26-25 06:45PM
04:15PM
Feb-14-25 01:12PM
Jan-29-25 04:15PM
Jan-24-25 12:48PM
Jan-15-25 07:55AM
Jan-02-25 04:15PM
Dec-06-24 10:02AM
Dec-02-24 04:15PM
Nov-13-24 09:29AM
Nov-07-24 10:38AM
02:27AM
Nov-06-24 07:05PM
04:15PM
Oct-28-24 04:15PM
Oct-16-24 04:15PM
Oct-15-24 08:05AM
Oct-09-24 04:15PM
Oct-02-24 04:15PM
Sep-27-24 07:20PM
Sep-24-24 08:00AM
Sep-18-24 08:00AM
Sep-17-24 11:02AM
Aug-28-24 07:03PM
Aug-21-24 04:15PM
Aug-15-24 04:15PM
Aug-12-24 03:57AM
Aug-07-24 12:25PM
Aug-06-24 06:25PM
04:15PM
Jul-09-24 04:45PM
Jul-02-24 04:15PM
Jun-17-24 08:00AM
May-29-24 04:15PM
May-21-24 08:00AM
May-09-24 02:45PM
May-08-24 01:16PM
05:48AM
04:13AM
May-07-24 06:40PM
05:59PM
04:15PM
May-06-24 03:19AM
Apr-16-24 08:00AM
Apr-09-24 04:15PM
Apr-04-24 07:01PM
Mar-02-24 08:41AM
Mar-01-24 07:10AM
Feb-29-24 06:05PM
04:52PM
04:10PM
Feb-01-24 04:30PM
Jan-31-24 11:03PM
Dec-13-23 04:30PM
Nov-21-23 04:30PM
Nov-10-23 01:22PM
Nov-09-23 10:41AM
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSep 09 '25Sale10.9251,224559,36673,979Sep 11 04:47 PM
Pedersen Leif EOfficerSep 09 '25Proposed Sale10.9251,224559,304Sep 09 04:16 PM
Anhalt RonaChief Human Resources OfficerMay 30 '25Option Exercise0.007,14607,146Jun 02 04:58 PM
Corcoran DanielSVP and General CounselMay 30 '25Option Exercise0.0022,828020,530Jun 02 04:57 PM
WALSH MATTHEW MDirectorMay 21 '25Option Exercise0.0011,9280197,559May 22 05:07 PM
Reynders John V WDirectorMay 21 '25Option Exercise0.0010,709010,709May 22 05:05 PM
Killefer NancyDirectorMay 21 '25Option Exercise0.0011,928036,089May 22 05:04 PM
Crane Rosemary ADirectorMay 21 '25Option Exercise0.0011,928029,915May 22 05:03 PM
Collins CynthiaDirectorMay 21 '25Option Exercise0.0011,928036,089May 22 05:01 PM
CASHMAN JAMES E IIIChairmanMay 21 '25Option Exercise0.0011,9280468,440May 22 05:00 PM
BROSHY ERANChairmanMay 21 '25Option Exercise0.0011,928034,951May 22 04:58 PM
Aspbury RobertPRESIDENT, PREDICTIVE TECHApr 01 '25Option Exercise0.0026,6260311,936Apr 03 04:44 PM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '25Option Exercise0.0026,6260127,669Apr 03 04:40 PM
Gallagher John EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '25Option Exercise0.0042,486051,731Apr 03 04:36 PM
Feehery William FCHIEF EXECUTIVE OFFICERApr 01 '25Option Exercise0.00111,39302,354,346Apr 03 04:32 PM
SMITH PATRICK FOfficerApr 02 '25Proposed Sale9.7320,142195,982Apr 02 10:57 AM
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONSOct 07 '24Sale11.035,40959,66150,091Oct 08 04:17 PM
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONSOct 04 '24Option Exercise0.007,151057,242Oct 07 04:42 PM
SMITH PATRICK FOfficerOct 07 '24Proposed Sale11.035,40959,661Oct 07 09:48 AM